HansBiomed Corporation (KQ:042520) — Market Cap & Net Worth
Market Cap & Net Worth: HansBiomed Corporation (042520)
HansBiomed Corporation (KQ:042520) has a market capitalization of $163.70 Million (₩241.56 Billion) as of August 4, 2026. Listed on the KQ stock exchange, this Korea-based company holds position #17249 globally and #661 in its home market, demonstrating a -11.00% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying HansBiomed Corporation's stock price ₩18600.00 by its total outstanding shares 12986979 (12.99 Million). See capital reinvestment ratio of HansBiomed Corporation to understand how much of operating cash flow is reinvested back into capital assets.
HansBiomed Corporation Market Cap History: 2015 to 2026
HansBiomed Corporation's market capitalization history from 2015 to 2026. Data shows growth from $165.21 Million to $163.70 Million (0.28% CAGR).
Index Memberships
HansBiomed Corporation is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
Kosdaq Composite Index
KOSDAQ
|
$202.56 Billion | 0.08% | #232 of 1384 |
|
Kosdaq Composite Index
KQ11
|
$202.56 Billion | 0.08% | #232 of 1384 |
Weight: HansBiomed Corporation's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
HansBiomed Corporation Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how HansBiomed Corporation's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.00x
HansBiomed Corporation's market cap is 0.00 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $140.68 Million | $29.05 Billion | $4.63 Billion | 0.00x | 0.03x |
| 2017 | $265.34 Million | $39.06 Billion | $7.83 Billion | 0.01x | 0.03x |
| 2018 | $217.82 Million | $51.75 Billion | $4.02 Billion | 0.00x | 0.05x |
| 2019 | $218.55 Million | $66.99 Billion | $9.95 Billion | 0.00x | 0.02x |
| 2020 | $119.25 Million | $80.10 Billion | -$17.84 Billion | 0.00x | N/A |
| 2021 | $99.89 Million | $59.10 Billion | -$18.29 Billion | 0.00x | N/A |
| 2022 | $86.60 Million | $74.46 Billion | $6.15 Billion | 0.00x | 0.01x |
| 2023 | $129.20 Million | $78.03 Billion | -$23.04 Billion | 0.00x | N/A |
| 2024 | $77.63 Million | $81.14 Billion | -$7.22 Billion | 0.00x | N/A |
| 2025 | $242.91 Million | $89.78 Billion | -$31.34 Billion | 0.00x | N/A |
Competitor Companies of 042520 by Market Capitalization
Companies near HansBiomed Corporation in the global market cap rankings as of August 4, 2026.
Key companies related to HansBiomed Corporation by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #114 globally with a market cap of $183.80 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #189 globally with a market cap of $124.64 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #233 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
- Medtronic PLC (NYSE:MDT): Ranked #238 globally with a market cap of $103.60 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #114 | Abbott Laboratories | NYSE:ABT | $183.80 Billion | $105.70 |
| #189 | Stryker Corporation | NYSE:SYK | $124.64 Billion | $325.70 |
| #233 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
| #238 | Medtronic PLC | NYSE:MDT | $103.60 Billion | $85.39 |
HansBiomed Corporation Historical Marketcap From 2015 to 2026
Between 2015 and today, HansBiomed Corporation's market cap moved from $165.21 Million to $ 163.70 Million, with a yearly change of 0.28%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₩163.70 Million | -32.61% |
| 2025 | ₩242.91 Million | +212.93% |
| 2024 | ₩77.63 Million | -39.92% |
| 2023 | ₩129.20 Million | +49.19% |
| 2022 | ₩86.60 Million | -13.30% |
| 2021 | ₩99.89 Million | -16.24% |
| 2020 | ₩119.25 Million | -45.43% |
| 2019 | ₩218.55 Million | +0.34% |
| 2018 | ₩217.82 Million | -17.91% |
| 2017 | ₩265.34 Million | +88.62% |
| 2016 | ₩140.68 Million | -14.85% |
| 2015 | ₩165.21 Million | -- |
End of Day Market Cap According to Different Sources
On Aug 3rd, 2026 the market cap of HansBiomed Corporation was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $163.70 Million USD |
| MoneyControl | $163.70 Million USD |
| MarketWatch | $163.70 Million USD |
| marketcap.company | $163.70 Million USD |
| Reuters | $163.70 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About HansBiomed Corporation
HansBiomed Corporation, together with its subsidiaries, engages in the research and development, production, and sale of medical materials for the procedure and the raw materials for medical supplies. The company provides ExFuse, a demineralized bone matrix with cancellous bone gel/putty; BellaFuse, a demineralized bone matrix; Genesis, a cancellous sponge block/filler; Pedi-Stick, a demineralize… Read more